Sorrentino et al., demonstrated that the mevalonate pathway, sustained by mutant p53 SREBPs activation increases YAP/TAZ oncogenic activity inducing cell proliferation and self-renewal in breast cancer cells [11] (Figure 2); moreover, YAP itself induces the transcription of several genes involved in cholesterol metabolism [250]. The gene discussed is YAP1; the disease is breast cancer.